BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 22634127)

  • 21. Prognosis and treatment of bile duct carcinoma.
    Chung C; Bautista N; O'Connell TX
    Am Surg; 1998 Oct; 64(10):921-5. PubMed ID: 9764692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of a novel cell line from intraductal papillary neoplasm of the bile duct.
    Murakami S; Ajiki T; Hori Y; Okazaki T; Fukumoto T; Ku Y
    Anticancer Res; 2014 May; 34(5):2203-9. PubMed ID: 24778022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
    J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyst-forming intraductal papillary neoplasm of the bile ducts: description of imaging and pathologic aspects.
    Lim JH; Zen Y; Jang KT; Kim YK; Nakanuma Y
    AJR Am J Roentgenol; 2011 Nov; 197(5):1111-20. PubMed ID: 22021503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and pathological features of intraductal papillary neoplasm of the biliary tract and gallbladder.
    Bennett S; Marginean EC; Paquin-Gobeil M; Wasserman J; Weaver J; Mimeault R; Balaa FK; Martel G
    HPB (Oxford); 2015 Sep; 17(9):811-8. PubMed ID: 26278323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological features of intraductal papillary neoplasms of the bile duct: a comparison with intraductal papillary mucinous neoplasm of the pancreas with reference to subtypes.
    Fukumura Y; Nakanuma Y; Kakuda Y; Takase M; Yao T
    Virchows Arch; 2017 Jul; 471(1):65-76. PubMed ID: 28550497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic delineation of papillary cholangiocarcinoma based on the invasive proportion: a single-institution study with 184 patients.
    Onoe S; Shimoyama Y; Ebata T; Yokoyama Y; Igami T; Sugawara G; Nakamura S; Nagino M
    Surgery; 2014 Feb; 155(2):280-91. PubMed ID: 24287144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
    Nakanishi Y; Zen Y; Kondo S; Itoh T; Itatsu K; Nakanuma Y
    Hum Pathol; 2008 Aug; 39(8):1153-61. PubMed ID: 18495210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma.
    Ahn KS; Kang KJ; Kang YN; Kim YH; Kim TS
    BMC Gastroenterol; 2016 Feb; 16():21. PubMed ID: 26911927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of intraductal papillary neoplasm of bile duct with respect to histopathologic similarities to pancreatic intraductal papillary mucinous neoplasm.
    Nakanuma Y; Kakuda Y; Uesaka K; Miyata T; Yamamoto Y; Fukumura Y; Sato Y; Sasaki M; Harada K; Takase M
    Hum Pathol; 2016 May; 51():103-13. PubMed ID: 27067788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of macroscopic morphology, multifocality, and mucin secretion on survival outcome of intraductal papillary neoplasm of the bile duct.
    Kang MJ; Jang JY; Lee KB; Han IW; Kim SW
    J Gastrointest Surg; 2013 May; 17(5):931-8. PubMed ID: 23371308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the Clinicopathologic Characteristics of Intraductal Papillary Neoplasm of the Bile Duct according to Morphological and Anatomical Classifications.
    Kim JR; Lee KB; Kwon W; Kim E; Kim SW; Jang JY
    J Korean Med Sci; 2018 Oct; 33(42):e266. PubMed ID: 30310366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma.
    Nakagohri T; Asano T; Kinoshita H; Kenmochi T; Urashima T; Miura F; Ochiai T
    World J Surg; 2003 Mar; 27(3):289-93. PubMed ID: 12607053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasound Findings of Intraductal Papillary Neoplasm in Bile Duct and the Added Value of Contrast-Enhanced Ultrasound.
    Liu LN; Xu HX; Zheng SG; Sun LP; Guo LH; Zhang YF; Xu JM; Liu C; Xu XH
    Ultraschall Med; 2015 Dec; 36(6):594-602. PubMed ID: 25188491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraductal tubular neoplasms of the bile ducts.
    Katabi N; Torres J; Klimstra DS
    Am J Surg Pathol; 2012 Nov; 36(11):1647-55. PubMed ID: 23073323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraductal Papillary Neoplasm of the Bile Duct: Clinical, Imaging, and Pathologic Features.
    Park HJ; Kim SY; Kim HJ; Lee SS; Hong GS; Byun JH; Hong SM; Lee MG
    AJR Am J Roentgenol; 2018 Jul; 211(1):67-75. PubMed ID: 29629808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct.
    Zen Y; Fujii T; Itatsu K; Nakamura K; Konishi F; Masuda S; Mitsui T; Asada Y; Miura S; Miyayama S; Uehara T; Katsuyama T; Ohta T; Minato H; Nakanuma Y
    Mod Pathol; 2006 Sep; 19(9):1243-54. PubMed ID: 16741522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological spectrum of intrahepatic cholangiocarcinoma arising in non-biliary chronic advanced liver diseases.
    Nakanuma Y; Xu J; Harada K; Sato Y; Sasaki M; Ikeda H; Kim J; Yu E
    Pathol Int; 2011 May; 61(5):298-305. PubMed ID: 21501296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraductal papillary neoplasm of the bile duct developing in a patient with primary sclerosing cholangitis: a case report.
    Hachiya H; Kita J; Shiraki T; Iso Y; Shimoda M; Kubota K
    World J Gastroenterol; 2014 Nov; 20(42):15925-30. PubMed ID: 25400480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological Study of Resections of Intraductal Papillary Neoplasm of the Bile Duct.
    Sato T; Hisaka T; Sakai H; Ishikawa H; Kawahara R; Goto Y; Nomura Y; Yasunaga M; Fujita F; Tanigawa M; Naito Y; Akiba J; Yano H; Tanaka H; Akagi Y; Okuda K
    Anticancer Res; 2019 Aug; 39(8):4569-4573. PubMed ID: 31366561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.